CIK 0001069530
- Non-accelerated filer
- Smaller reporting company
FILANA THERAPEUTICS, INC.
Sign in to watch- Ticker
- FLNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 911911336
- Phone
- +1 512-501-2444
- Business address
- 6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300, AUSTIN, TX, 78731
- Former names
- CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
- Open-market buys, last 90 days
- $627,549
- in 5 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$627,549. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-16 | Cook Robert Christopher Chief Operating& Legal Officer | Purchase | +121,575 | $0.46 | $56K | 135,300 |
| 2025-09-30 | Cook Robert Christopher Chief Operating & Legal Office | Purchase | +13,725 | $2.91 | $40K | 13,725 |
| 2025-04-17 | Cook Robert Christopher Chief Operating & Legal Office | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2024-09-06 | Cook Robert Christopher SVP & General Counsel | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2024-05-20 | Cook Robert Christopher SVP & General Counsel | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2023-10-03 | Cook Robert Christopher SVP & General Counsel | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2022-10-28 | Cook Robert Christopher SVP & General Counsel | Grant or award · Employee Stock Option (right to buy) | +100,000 | $36.76 | $3.7M | 100,000 |
Page 1 of 1 · 7 trades